New Legacy Group, LLC

SEC CIK: 0001908065
Latest filing: Nov 14, 2023

SEC filings (opens in a new tab)

PHAS holding history

PhaseBio Pharmaceuticals Inc in every 13F filed by New Legacy Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PHAS overview All 13F holders of PHAS Full Q3 2023 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q4 2021

Holdings of PHAS by New Legacy Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−240,575−100.0%	Sold out	Holders
Q2 2022	240,575	$144.0K	0.3%	00.0%	Unchanged	Holders
Q1 2022	240,575	$318.0K	0.1%	00.0%	Unchanged	Holders
Q4 2021	240,575	$628.0K	0.1%	–	No prior filing	Holders